NasdaqGS - Nasdaq Real Time Price USD

Kanzhun Limited (BZ)

Compare
15.12 -0.98 (-6.09%)
At close: October 15 at 4:00 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 1.92B
Earnings 421.73M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

11.46 Low
17.82 Average
15.12 Current
23.92 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 661718
Avg. Estimate 0.210.220.820.98
Low Estimate 0.190.210.730.88
High Estimate 0.220.230.941.13
Year Ago EPS 0.220.20.670.82

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1092021
Avg. Estimate 267.85M265.52M1.05B1.25B
Low Estimate 260.48M254.05M1.03B1.2B
High Estimate 270.86M281.39M1.06B1.42B
Year Ago Sales 223.36M222.03M836.28M1.05B
Sales Growth (year/est) 19.90%19.60%25.00%19.90%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. 0.150.170.130.21
EPS Actual 0.220.20.160.22
Difference 0.070.030.030.01
Surprise % 46.70%17.60%23.10%4.80%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.210.220.820.98
7 Days Ago 0.210.220.830.98
30 Days Ago 0.210.220.820.98
60 Days Ago 0.210.220.810.99
90 Days Ago 0.230.230.841.05

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days 11----
Down Last 7 Days --------
Down Last 30 Days 1111

Growth Estimates

CURRENCY IN USD BZIndustrySectorS&P 500
Current Qtr. -4.50%----4.40%
Next Qtr. 10.00%----7.80%
Current Year 22.40%----2.50%
Next Year 19.50%----13.10%
Next 5 Years (per annum) 2.92%----11.89%
Past 5 Years (per annum) 29.75%------

Upgrades & Downgrades

Maintains Barclays: Overweight to Overweight 8/30/2024
Maintains UBS: Neutral to Neutral 5/22/2024
Maintains JP Morgan: Overweight to Overweight 5/22/2024
Maintains Barclays: Overweight to Overweight 3/13/2024
Upgrade New Street Research: Neutral to Buy 3/13/2024
Upgrade Macquarie: Neutral to Outperform 3/12/2024

Related Tickers